The Division of Blood Diseases and Resources (DBDR) is part of the National Heart, Lung, and Blood Institute (NHLBI), one of 27 institutes and centers at the National Institutes of Health (NIH). DBDR supports research on the causes, prevention, and treatment of nonmalignant blood diseases, including anemias, sickle cell disease, and thalassemia; premalignant processes such as myelodysplasia and myeloproliferative disorders; hemophilia and other abnormalities of hemostasis and thrombosis; and immune dysfunction. Funding encompasses a broad spectrum of research ranging from basic biology to medical management of blood diseases.
The Division has a major responsibility for research to assure the adequacy and safety of the Nation's blood supply. The Division also has a leading role in applying scientific advances in transfusion medicine and stem cell biology to the development of new cell-based therapies to repair and regenerate human tissues and organs. DBDR has three branches: the Blood Epidemiology and Therapeutics Branch, the Molecular Cellular and Systems Blood Science Branch, and the Translational Blood Science and Resources Branch.
Office Of The Director
This Branch 1) Plans, coordinates, and manages activities of all subdivisions responsible for hematologic, transfusion medicine, transplantation, and AIDS programs; (2) maintains continuing assessment of the Institute's national and international health programs related to hematology, transfusion medicine, and tissue and cellular transplantation; (3) fosters and coordinates interdivision and interagency collaborative and cooperative research arrangements; (4) develops and maintains the necessary scientific management capability in the Division to foster and guide effective programs in blood diseases and the management of transfusion and tissue transplantation; (5) plans, coordinates, and directs special activities which transcend program lines including minority, small business, and demonstration and education research programs; and (6) provides administrative support services for the Division.
W. Keith Hoots, MD, Director
Blood Epidemiology and Therapeutics Branch
Oversight, support and stimulation of epidemiologic, clinical and implementation research throughout the spectrum of blood science. Branch responsibilities will include: 1) oversight, support and stimulation of epidemiologic, health services and observational clinical research; 2) oversight, support and stimulation of therapeutic and interventional clinical trials [T3 Research]; 3) acquisition and maintenance of expertise in clinical study and trail design and administration on behalf of the Division; 4) oversight, support and stimulation of implementation science and research [T4Research]; 5) training of the blood science workforce; and, 6) scientific liaison for epidemiologic, clinical and implementation research across the Division, NHLBI, NIH and partner federal agencies.
Simone Glynn, M.D., Branch Chief
Molecular Cellular and Systems Blood Science Branch
Oversight, support and stimulation of fundamental basic research and early stage laboratory translation of the biology of blood, the blood forming elements and the interface between each ofthe latter with other cellular and organ systems. Branch responsibilities will include: 1) oversight, support and stimulation of discovery science focused on the explication of the physiology and pathophysiology of blood, bone marrow and blood vessels; 2) oversight, support and stimulation of systems biological approaches to understanding the critical role of blood/bone marrow/vascular endothelium in animal and human organs and organisms; 3) oversight, support and stimulation of the application of fundamental genetic, proteomic and metabolomic tools to understanding hematologic physiology and pathophysiology; 4) administration of and/or liaison to NHLBIINIH resources related to basic research in non-neoplastic hematology; 5) training of the blood science workforce; and, 6) fostering scientific communication across the Division, NHLBI, NIH and partner federal agencies to engender bench to bedside translation.
Dr. Yu-Chung Yang, Ph.D., Branch Chief
Translational Blood Science and Resources Branch
Oversight, support and stimulation of translational research throughout the spectrum of blood science, as well as the resources required to support heart, lung, blood, and sleep research. Branchy responsibilities will include: 1) oversight, support and stimulation of post-discovery science, preclinical research, and early phase clinical studies and trails [T1,T2 Research]; 2) oversight, support and stimulation of SBIR/STTR initiatives in blood sciences; 30 administration of and/or liaison to NLBI resources related to translation research; 4) training of the blood science workforce; and, 5) scientific liaison for translation research across the Division, NHLBI, NIH and partner federal agencies.
Traci Heath Mondoro, Ph.D.
Division of Blood Diseases and Resources
The National Heart, Lung and Blood Institute
Two Rockledge Center, Suite 9030
6701 Rockledge Dr. MSC 7950
Bethesda, Maryland 20892-7950
Additional phone numbers are available in the Abbreviated Staff Directory